Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Indulgence
Premium
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
NPPA allows differential price for Meril's biodegradable cardiac stent
The National Pharmaceutical Pricing Authority (NPPA) invoked the para 32 (ii) of the Drug Price Control Order, 2013 to grant the exemption to the indigenously developed stent
Domestic stent market on a healthy growth track despite price controls
According to industry estimates in 2018 calendar year the overall Indian cardiac stent market grew by 16-18 per cent in terms of volumes
Poor diagnosis
Price control on stents should have been thought through
NPPA increases stent prices by around 2% effective Saturday
NPPA has also fixed ceiling price of 46 drug formulations used for various ailments
